WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus on ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Notably, the authors did not know whether people who visited the hospital were taking Ozempic, Wegovy, or a copycat semaglutide prepared by pharmacists. Cohen said taking a compounded semaglutide ...

after the healthcare-services company dropped a bombshell on investors — it’s leaving the Obamacare business and will increase access to weight-loss drug Wegovy as it reported blowout earnings.

The organization plans to back GLP-1s like Wegovy and Zepbound to treat obesity in adults as part of a shift in addressing the global obesity epidemic, as reported by Reuters. In a memo ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side effects are sending some users to the ER. The study outlined the top reasons ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists ...

GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...

By Dani Blum I’ve reported on Ozempic since 2022. New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study ...